<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d379" origId="Cefditoren"><sentence id="DrugDDI.d379.s0" origId="s0" text="Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives."><entity charOffset="0-19" id="DrugDDI.d379.s0.e0" origId="s0.p0" text="oral contraceptives" type="drug"/><entity charOffset="38-56" id="DrugDDI.d379.s0.e1" origId="s0.p1" text="cefditoren pivoxil" type="drug"/><entity charOffset="98-115" id="DrugDDI.d379.s0.e2" origId="s0.p5" text="ethinyl estradiol" type="drug"/><entity charOffset="121-131" id="DrugDDI.d379.s0.e3" origId="s0.p6" text="estrogenic" type="drug"/><entity charOffset="150-169" id="DrugDDI.d379.s0.e4" origId="s0.p7" text="oral contraceptives" type="drug"/><pair e1="DrugDDI.d379.s0.e0" e2="DrugDDI.d379.s0.e1" id="DrugDDI.d379.s0.p0" interaction="false"/><pair e1="DrugDDI.d379.s0.e0" e2="DrugDDI.d379.s0.e2" id="DrugDDI.d379.s0.p1" interaction="false"/><pair e1="DrugDDI.d379.s0.e0" e2="DrugDDI.d379.s0.e3" id="DrugDDI.d379.s0.p2" interaction="false"/><pair e1="DrugDDI.d379.s0.e0" e2="DrugDDI.d379.s0.e4" id="DrugDDI.d379.s0.p3" interaction="false"/><pair e1="DrugDDI.d379.s0.e1" e2="DrugDDI.d379.s0.e2" id="DrugDDI.d379.s0.p4" interaction="false"/><pair e1="DrugDDI.d379.s0.e1" e2="DrugDDI.d379.s0.e3" id="DrugDDI.d379.s0.p5" interaction="false"/><pair e1="DrugDDI.d379.s0.e1" e2="DrugDDI.d379.s0.e4" id="DrugDDI.d379.s0.p6" interaction="false"/><pair e1="DrugDDI.d379.s0.e2" e2="DrugDDI.d379.s0.e3" id="DrugDDI.d379.s0.p7" interaction="false"/><pair e1="DrugDDI.d379.s0.e2" e2="DrugDDI.d379.s0.e4" id="DrugDDI.d379.s0.p8" interaction="false"/><pair e1="DrugDDI.d379.s0.e3" e2="DrugDDI.d379.s0.e4" id="DrugDDI.d379.s0.p9" interaction="false"/><negationtags>Oral Contraceptives Multiple doses of cefditoren pivoxil had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; effect on the pharmacokinetics of ethinyl estradiol&lt;/xcope&gt;, the estrogenic component in most oral contraceptives.</negationtags></sentence><sentence id="DrugDDI.d379.s1" origId="s1" text="Antacids Co-administration of a single dose of an antacid which contained both magnesium (800 mg) and aluminum (900 mg) hydroxides reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 14% decrease in mean Cmax and an 11% decrease in mean AUC."><entity charOffset="0-8" id="DrugDDI.d379.s1.e0" origId="s1.p8" text="Antacids" type="drug"/><entity charOffset="50-57" id="DrugDDI.d379.s1.e1" origId="s1.p10" text="antacid" type="drug"/><entity charOffset="79-88" id="DrugDDI.d379.s1.e2" origId="s1.p14" text="magnesium" type="drug"/><entity charOffset="186-204" id="DrugDDI.d379.s1.e3" origId="s1.p27" text="cefditoren pivoxil" type="drug"/><pair e1="DrugDDI.d379.s1.e0" e2="DrugDDI.d379.s1.e1" id="DrugDDI.d379.s1.p0" interaction="false"/><pair e1="DrugDDI.d379.s1.e0" e2="DrugDDI.d379.s1.e2" id="DrugDDI.d379.s1.p1" interaction="false"/><pair e1="DrugDDI.d379.s1.e0" e2="DrugDDI.d379.s1.e3" id="DrugDDI.d379.s1.p2" interaction="false"/><pair e1="DrugDDI.d379.s1.e1" e2="DrugDDI.d379.s1.e2" id="DrugDDI.d379.s1.p3" interaction="false"/><pair e1="DrugDDI.d379.s1.e1" e2="DrugDDI.d379.s1.e3" id="DrugDDI.d379.s1.p4" interaction="true"/><pair e1="DrugDDI.d379.s1.e2" e2="DrugDDI.d379.s1.e3" id="DrugDDI.d379.s1.p5" interaction="false"/></sentence><sentence id="DrugDDI.d379.s2" origId="s2" text="Although the clinical significance is not known, it is not recommended that cefditoren pivoxil be taken concomitantly with antacids."><entity charOffset="76-94" id="DrugDDI.d379.s2.e0" origId="s2.p48" text="cefditoren pivoxil" type="drug"/><entity charOffset="123-131" id="DrugDDI.d379.s2.e1" origId="s2.p52" text="antacids" type="drug"/><pair e1="DrugDDI.d379.s2.e0" e2="DrugDDI.d379.s2.e1" id="DrugDDI.d379.s2.p0" interaction="true"/><negationtags>Although the clinical significance is &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; known, &lt;xcope&gt;it is &lt;cue&gt;not&lt;/cue&gt; recommended that cefditoren pivoxil be taken concomitantly with antacids&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d379.s3" origId="s3" text="H2-Receptor Antagonists Co-administration of a single dose of intravenously administered famotidine (20 mg) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC."><entity charOffset="0-23" id="DrugDDI.d379.s3.e0" origId="s3.p53" text="h2-receptor antagonists" type="drug"/><entity charOffset="89-99" id="DrugDDI.d379.s3.e1" origId="s3.p55" text="famotidine" type="drug"/><entity charOffset="163-181" id="DrugDDI.d379.s3.e2" origId="s3.p62" text="cefditoren pivoxil" type="drug"/><pair e1="DrugDDI.d379.s3.e0" e2="DrugDDI.d379.s3.e1" id="DrugDDI.d379.s3.p0" interaction="false"/><pair e1="DrugDDI.d379.s3.e0" e2="DrugDDI.d379.s3.e2" id="DrugDDI.d379.s3.p1" interaction="false"/><pair e1="DrugDDI.d379.s3.e1" e2="DrugDDI.d379.s3.e2" id="DrugDDI.d379.s3.p2" interaction="true"/></sentence><sentence id="DrugDDI.d379.s4" origId="s4" text="Although the clinical significance is not known, it is not recommended that cefditoren pivoxil be taken concomitantly with H2 receptor antagonists."><entity charOffset="76-94" id="DrugDDI.d379.s4.e0" origId="s4.p83" text="cefditoren pivoxil" type="drug"/><entity charOffset="123-134" id="DrugDDI.d379.s4.e1" origId="s4.p87" text="H2 receptor" type="drug"/><pair e1="DrugDDI.d379.s4.e0" e2="DrugDDI.d379.s4.e1" id="DrugDDI.d379.s4.p0" interaction="true"/><negationtags>Although the clinical significance is &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; known, &lt;xcope&gt;it is &lt;cue&gt;not&lt;/cue&gt; recommended that cefditoren pivoxil be taken concomitantly with H2 receptor antagonists&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d379.s5" origId="s5" text="Probenecid As with other b-lactam antibiotics, co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren, with a 49% increase in mean Cmax, a 122% increase in mean AUC, and a 53% increase in half-life."><entity charOffset="0-10" id="DrugDDI.d379.s5.e0" origId="s5.p88" text="Probenecid" type="drug"/><entity charOffset="25-45" id="DrugDDI.d379.s5.e1" origId="s5.p90" text="b-lactam antibiotics" type="drug"/><entity charOffset="68-78" id="DrugDDI.d379.s5.e2" origId="s5.p92" text="probenecid" type="drug"/><entity charOffset="84-102" id="DrugDDI.d379.s5.e3" origId="s5.p93" text="cefditoren pivoxil" type="drug"/><entity charOffset="153-163" id="DrugDDI.d379.s5.e4" origId="s5.p97" text="cefditoren" type="drug"/><pair e1="DrugDDI.d379.s5.e0" e2="DrugDDI.d379.s5.e1" id="DrugDDI.d379.s5.p0" interaction="false"/><pair e1="DrugDDI.d379.s5.e0" e2="DrugDDI.d379.s5.e2" id="DrugDDI.d379.s5.p1" interaction="false"/><pair e1="DrugDDI.d379.s5.e0" e2="DrugDDI.d379.s5.e3" id="DrugDDI.d379.s5.p2" interaction="false"/><pair e1="DrugDDI.d379.s5.e0" e2="DrugDDI.d379.s5.e4" id="DrugDDI.d379.s5.p3" interaction="false"/><pair e1="DrugDDI.d379.s5.e1" e2="DrugDDI.d379.s5.e2" id="DrugDDI.d379.s5.p4" interaction="false"/><pair e1="DrugDDI.d379.s5.e1" e2="DrugDDI.d379.s5.e3" id="DrugDDI.d379.s5.p5" interaction="false"/><pair e1="DrugDDI.d379.s5.e1" e2="DrugDDI.d379.s5.e4" id="DrugDDI.d379.s5.p6" interaction="false"/><pair e1="DrugDDI.d379.s5.e2" e2="DrugDDI.d379.s5.e3" id="DrugDDI.d379.s5.p7" interaction="true"/><pair e1="DrugDDI.d379.s5.e2" e2="DrugDDI.d379.s5.e4" id="DrugDDI.d379.s5.p8" interaction="false"/><pair e1="DrugDDI.d379.s5.e3" e2="DrugDDI.d379.s5.e4" id="DrugDDI.d379.s5.p9" interaction="false"/></sentence><sentence id="DrugDDI.d379.s6" origId="s6" text="Drug/Laboratory Test Interactions Cephalosporins are known to occasionally induce a positive direct Coombs test."><entity charOffset="0-4" id="DrugDDI.d379.s6.e0" origId="s6.p105" text="Drug" type="drug"/><entity charOffset="34-48" id="DrugDDI.d379.s6.e1" origId="s6.p106" text="Cephalosporins" type="drug"/><pair e1="DrugDDI.d379.s6.e0" e2="DrugDDI.d379.s6.e1" id="DrugDDI.d379.s6.p0" interaction="false"/></sentence><sentence id="DrugDDI.d379.s7" origId="s7" text="A false-positive reaction for glucose in the urine may occur with copper reduction tests (Benedicts or Fehlings solution or with CLINITEST tablets), but not with enzyme-based tests for glycosuria (e.g., CLINISTIX, TES-TAPE)."><entity charOffset="30-37" id="DrugDDI.d379.s7.e0" origId="s7.p113" text="glucose" type="drug"/></sentence><sentence id="DrugDDI.d379.s8" origId="s8" text="As a false-negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase method be used to determine blood/plasma glucose levels in patients receiving cefditoren pivoxil."><entity charOffset="97-112" id="DrugDDI.d379.s8.e0" origId="s8.p144" text="glucose oxidase" type="drug"/><entity charOffset="116-126" id="DrugDDI.d379.s8.e1" origId="s8.p146" text="hexokinase" type="drug"/><entity charOffset="205-223" id="DrugDDI.d379.s8.e2" origId="s8.p155" text="cefditoren pivoxil" type="drug"/><pair e1="DrugDDI.d379.s8.e0" e2="DrugDDI.d379.s8.e1" id="DrugDDI.d379.s8.p0" interaction="false"/><pair e1="DrugDDI.d379.s8.e0" e2="DrugDDI.d379.s8.e2" id="DrugDDI.d379.s8.p1" interaction="false"/><pair e1="DrugDDI.d379.s8.e1" e2="DrugDDI.d379.s8.e2" id="DrugDDI.d379.s8.p2" interaction="false"/></sentence></document>